US$ 20.31
medicare and glp-1 coverage MCT2D Navigating Medicare's $50 GLP-1 Program:
Description
IIH patients treated with GLP-1Ras also required lower doses of acetazolamide compared to controls (10)

Evaluating the Cardiovascular Safety and Efficacy of Tirzepatide in Patients With T2DM In addition, the direct impact of tirzepatide on the incidence of cardiovascular complications has been evaluated

(Lond.) 36 , 2734 (2012)
#13 Edit: meant to put this in the specific Semaglutide thread.

Most providers recommend a four-to-eight week trial period